Fate Therapeutics (STU:F6T) Accumulated Depreciation : €0.00 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Fate Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Fate Therapeutics's quarterly accumulated depreciation increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€-33.56 Mil) but then stayed the same from Dec. 2024 (€-33.56 Mil) to Mar. 2025 (€0.00 Mil).

Fate Therapeutics's annual accumulated depreciation increased from Dec. 2022 (€-28.68 Mil) to Dec. 2023 (€-43.67 Mil) but then stayed the same from Dec. 2023 (€-43.67 Mil) to Dec. 2024 (€-33.56 Mil).

Fate Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Fate Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fate Therapeutics Accumulated Depreciation Chart

Fate Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-9.12

-15.00

-28.68

-43.67

-33.56

Fate Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-33.56	-

Fate Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Fate Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Fate Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Fate Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fate Therapeutics Inc (STU:F6T) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

FATE:USA F6T:Germany

Address

12278 Scripps Summit Drive, San Diego, CA, USA, 92131

Website

https://www.fatetherapeutics.com

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Fate Therapeutics Headlines

No Headlines